To better investigate the role of PLC-β2 in modulating the stem cell phenotype of TNBC cells, we also evaluated the surface expression of CD44, a well-described cancer stem cell marker in breast tumors and a negative prognosticator in TNBC [33]. Here, CD44 is linked to breast neoplasm.